Boston Scientific Corporation (BSX) shares fell 16.79 percent, or $15.39, to $76.24 on Wednesday, despite reporting higher fourth-quarter earnings year over year.
Net income rose to $672 million, or $0.45 per share, from $566 million, or $0.38 per share, last year. Adjusted earnings increased to $0.80 per share, while revenue climbed 15.9 percent to $5.29 billion.
The stock opened at $81.38 and traded between $76.20 and $81.78 on the New York Stock Exchange. Trading volume was about 13.3 million shares, above the average of 10.45 million. The 52-week range is $76.20 to $109.50.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.